In celebration of the California Institute for Regenerative Medicine (CIRM)’s 20th anniversary, we have been reflecting on some of the early projects, particularly the education and training programs, that we supported and their outcomes. In the beginning Today, we’re looking at our first set of grants, which we awarded in 2006 to support training programs … Continue reading 20 Years of CIRM: Building the Workforce
CIRM
20 Years of CIRM: From building the infrastructure to clinical trials
Californians voted to support stem cell research 20 years ago. Now we’re building on what we’ve created through the California Institute for Regenerative Medicine (CIRM). Their initial $3 billion investment through Proposition 71 paved the way for voters to approve Proposition 14 in 2020. That added another $5.5 billion to advance the science. CIRM will … Continue reading 20 Years of CIRM: From building the infrastructure to clinical trials
Honoring Dr. John Zaia: A Legacy of Science, Leadership, and Kindness
Photo Courtesy: City of Hope The scientific community lost a true pioneer with the passing of John A. Zaia, MD. Dr. Zaia was a visionary virologist, gene therapy trailblazer, and esteemed leader at City of Hope. He dedicated over four decades to advancing regenerative medicine. He left behind a profound impact on HIV research, pediatric … Continue reading Honoring Dr. John Zaia: A Legacy of Science, Leadership, and Kindness
The Link Between Air Pollution and Autism
The California Institute for Regenerative Medicine (CIRM) is supporting innovative research into neuro diseases, including a project examining how air pollution may contribute to autism. Through the Research using Multidisciplinary, Innovative approaches in Neuro Diseases (ReMIND) program, Stuart Lipton, MD, PhD, and co-investigators Tomo Nakamura, PhD, John Yates, PhD, Marisa Roberto, PhD, and Nik Schork, … Continue reading The Link Between Air Pollution and Autism
Remembering CIRM board member and ALS patient advocate Fred Fisher
CIRM honors the contributions of Fred Fisher, MSW, LCSW, a dedicated member of our Independent Citizens’ Oversight Committee (ICOC) and a passionate patient advocate. Fred passed away in September. He joined the ICOC as the ALS patient advocate in June 2021 and served in many roles, including co‑chair of the Standards Working Group and member … Continue reading Remembering CIRM board member and ALS patient advocate Fred Fisher
Strategic Framework Impacts the Future of CIRM’s Research Funding
As the regenerative medicine field rapidly evolves, CIRM faces a key challenge: investing the remaining $3.86 billion in ways that deliver the greatest impact for Californians. To meet this challenge, CIRM launched the Strategic Allocation Framework (SAF) to prioritize resources and maximize the potential of regenerative medicine breakthroughs. What is the SAF? The SAF uses … Continue reading Strategic Framework Impacts the Future of CIRM’s Research Funding
A new generation in the golden era of regenerative medicine
CIRM CEO and President, Jonathan 'JT' Thomas, speaking in front of conference attendees. At this year's California Institute for Regenerative Medicine Trainee Networking Conference, the young scientists assembled heard it loud and clear: this is the time, and California is the place for regenerative medicine. “You’re in the golden era of biomedical innovation,” said CIRM … Continue reading A new generation in the golden era of regenerative medicine
Where Are They Now: Jake Javier
On the first day, of the 2024 CIRM Trainee Network Conference, Jake Javier took shared his experience as a clinical trial patient, as how he benefited from the innovative trial. The event done in partnership with the University of Southern California (USC) gave trainees from CIRM’s education and training programs an opportunity to engage with … Continue reading Where Are They Now: Jake Javier
Meet Our New CEO: Jonathan Thomas
We are excited to reintroduce Jonathan Thomas (JT) as the new President and CEO of the California Institute for Regenerative Medicine. You can read the original press release here. We recently spoke with JT, who previously served as Chair of the Independent Citizens’ Oversight Committee and as interim President and CEO. He discussed what excites … Continue reading Meet Our New CEO: Jonathan Thomas
A CIRM Bridges Trainee’s Path into Regenerative Medicine
Josh Nelson, a former technical director for various theaters, tapped into CIRM's Bridges program at Cal Poly Humbolt to establish a career in regenerative medicine research.